ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Richard M. Engelman
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engelman, R. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Engelman, R. M.
Related Collections
Right arrow Extracorporeal circulation
Right arrowRelated Article

Ann Thorac Surg 2001;72:526
© 2001 The Society of Thoracic Surgeons

Invited commentary

Richard M. Engelman, MDa

a Division of Cardiac Surgery, Baystate Medical Center, 759 Chestnut St, Springfield, MA 01107, USA

e-mail: engelman@bhs.org

In my experience and in fact the experience of the hematology services and hospital pharmacies in institutions performing cardiac surgery, it is not uncommon to have an antifibrinolytic agent, eg Aprotinin or EACA, administered hours after the end of the fibrinolytic insult, eg cardiopulmonary bypass, when unusual postoperative bleeding is appreciated. This is discussed in this . . . [Full Text of this Article]


Related Article

Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit
Michael J. Ray, Majella M. Hales, Lee Brown, Mark F. O’Brien, and E. Gregory Stafford
Ann. Thorac. Surg. 2001 72: 521-526. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.